10 April, 2024Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis
8 April, 2024Sensorion announces a €15 Million financing, extending cash runway until the end of 2025
20 March, 2024Cure51 raises a €15 million seed round to harness the natural power of cancer survivors to develop first in class treatments and transform cancer into a curable disease